Decoding DNA methylation in epigenetics of multiple myeloma

Area of Science:

• Epigenetics
• Cancer Biology
• Hematology

Background:

• DNA methylation dysregulation is implicated in B-cell neoplastic transformation and associated with B-cell malignancies.
• Multiple myeloma (MM), a plasma cell malignancy, exhibits significant alterations in DNA methylation, impacting genome stability and gene transcription.
• Aberrant expression of DNA methylation-modifying enzymes correlates with MM development, progression, and patient prognosis.

Purpose of the Study:

• To review the current understanding of DNA methylome alterations in MM.
• To focus on the roles of DNA methyltransferases (DNMTs) and tet methylcytosine dioxygenases (TETs) in MM.
• To explore the regulation and function of these epigenetic modifiers in MM cells for potential therapeutic strategies.

Main Methods:

• Review of existing literature on DNA methylation and MM.
• Analysis of studies focusing on DNA methyltransferases (DNMTs).
• Examination of research on tet methylcytosine dioxygenases (TETs) in the context of MM.

Main Results:

• Pronounced alterations in the DNA methylome, including global and gene-specific changes, are evident in MM.
• Dysregulated expression of DNA methylation modifiers (DNMTs, TETs) is associated with MM pathogenesis.
• The functional roles of these epigenetic abnormalities in MM remain incompletely understood.

Conclusions:

• Epigenetic alterations involving DNA methylation are a hallmark of multiple myeloma.
• Further research into DNMTs and TETs in MM is crucial for elucidating their functional roles.
• Targeting DNA methylation pathways presents a promising avenue for novel epigenetic therapies in MM.